Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Parapsoriasis 1Lymphoma, Follicular 1Dermatitis, Contact 1Acne Vulgaris 1

Interventions

Injections, Intradermal 1Gels 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Acne Vulgaris × Gels × Lymphoid × Clear all
NCT02796066 2017-04-26

TSN2898-201 Safety and Efficacy of TSN2898 in the Treatment of Acne Vulgaris

Thesan Pharmaceuticals, Inc.

Phase 2 Withdrawn
Lymphoid

Acne Vulgaris, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡